- Home
- IGMS vs FKWL Comparison
IGMS vs FKWL Comparison
Compare IGMS & FKWL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- IGMS
- FKWL
- Stock Information
- Founded
- IGMS 1993
- FKWL 1981
- Country
- IGMS United States
- FKWL United States
- Employees
- IGMS N/A
- FKWL N/A
- Industry
- IGMS Biotechnology: Pharmaceutical Preparations
- FKWL Telecommunications Equipment
- Sector
- IGMS Health Care
- FKWL Utilities
- Exchange
- IGMS Nasdaq
- FKWL Nasdaq
- Market Cap
- IGMS 82.1M
- FKWL 71.6M
- IPO Year
- IGMS 2019
- FKWL 1996
- Fundamental
- Price
- IGMS $1.24
- FKWL $5.60
- Analyst Decision
- IGMS Hold
- FKWL
- Analyst Count
- IGMS 8
- FKWL 0
- Target Price
- IGMS $6.14
- FKWL N/A
- AVG Volume (30 Days)
- IGMS 198.4K
- FKWL 41.3K
- Earning Date
- IGMS 03-06-2025
- FKWL 05-14-2025
- Dividend Yield
- IGMS N/A
- FKWL N/A
- EPS Growth
- IGMS N/A
- FKWL N/A
- EPS
- IGMS N/A
- FKWL N/A
- Revenue
- IGMS $2,679,000.00
- FKWL $43,443,375.00
- Revenue This Year
- IGMS $134.71
- FKWL N/A
- Revenue Next Year
- IGMS $74.27
- FKWL N/A
- P/E Ratio
- IGMS N/A
- FKWL N/A
- Revenue Growth
- IGMS 25.77
- FKWL N/A
- 52 Week Low
- IGMS $1.15
- FKWL $2.90
- 52 Week High
- IGMS $22.50
- FKWL $7.45
- Technical
- Relative Strength Index (RSI)
- IGMS 37.38
- FKWL 42.15
- Support Level
- IGMS $1.17
- FKWL $5.34
- Resistance Level
- IGMS $1.31
- FKWL $6.23
- Average True Range (ATR)
- IGMS 0.09
- FKWL 0.42
- MACD
- IGMS 0.05
- FKWL -0.07
- Stochastic Oscillator
- IGMS 32.14
- FKWL 40.68
About IGMS IGM Biosciences Inc.
IGM Biosciences Inc is a biotechnology company engaged in the development of IgM antibody therapeutics for the treatment of cancer, infectious diseases, and autoimmune and inflammatory diseases. Its IgM antibody technology platform is suited for developing T cell engagers, receptor cross-linking agonists, and targeted cytokines. Its product candidate, Aplitabart: An IgM antibody targeting Death Receptor 5 (DR5) proteins, for the treatment of colorectal cancer; Imvotamab: A bispecific for severe systemic lupus erythematosus (SLE) and one for severe rheumatoid arthritis (RA); and IGM-2644: A bispecific T cell engaging IgM antibody targeting CD38 and CD3 proteins, currently planned for evaluation in autoimmune disease.
About FKWL Franklin Wireless Corp.
Franklin Wireless Corp is a provider of wireless solutions, including mobile hotspots, routers, and modems, as well as hardware and software products that support machine-to-machine (M2M) applications and the Internet of Things (IoT). Its M2M and IoT solutions include embedded modules, modems, and gateways built to deliver reliable always-on connectivity supporting a spectrum of applications. These products are designed to solve wireless connectivity challenges in a range of vertical markets, including video surveillance, digital signage, home security, oil and gas exploration, kiosks, fleet management, smart grid, vehicle diagnostics, and telematics.